In this Issue:
Bowel dysfunction after surgery for rectal cancer
In CRC:
Low CLCA1 predicts poor prognosis
Detrimental effect of cetuximab in RAS mutants
Aprepitant for prevention of CINV
Long-term amenorrhoea with chemoradiotherapy
In mCRC:
Regorafenib improves OS
Ramucirumab + FOLFIRI improves OS
Pimasertib study limited by toxicity
EGFR therapy superior to VEGF therapy
Chemotherapy for patients with poor performance status
Please login below to download this issue (PDF)